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Abstract The non-therapeutic use of genes to enhance
athletic performance (gene doping) is a novel threat to the
World of Sports. Skeletal muscle is a prime target of gene
therapy and we asked whether we can develop a test system
to produce and detect gene doping. Towards this end, we
introduced a plasmid (pCMV-FAK, 3.8 kb, 50 g) for con-
stitutive expression of the chicken homologue for the regu-
lator of muscle growth, focal adhesion kinase (FAK), via
gene electro transfer in the anti-gravitational muscle,
m. soleus, or gastrocnemius medialis of rats. Activation of
hypertrophy signalling was monitored by assessing the
ribosomal kinase p70S6K and muscle Wbre cross section.
Detectability of the introduced plasmid was monitored with
polymerase chain reaction in deoxyribonucleic acids
(DNA) from transfected muscle and serum. Muscle trans-
fection with pCMV-FAK elevated FAK expression 7- and
73-fold, respectively, and increased mean cross section by
52 and 16% in targeted muscle Wbres of soleus and gastroc-
nemius muscle 7 days after gene electro transfer. Concomi-
tantly p70S6K content was increased in transfected soleus
muscle (+110%). Detection of the exogenous plasmid
sequence was possible in DNA and cDNA of muscle until
7 days after transfection, but not in serum except close to
the site of plasmid deposition, 1 h after injection and sur-
gery. The Wndings suggest that the reliable detection of
gene doping in the immoral athlete is not possible unless a
change in the current practice of tissue sampling is applied
involving the collection of muscle biopsy close to the site
of gene injection.
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Introduction
Gene doping is a new threat to the world of sports which
arose as a spin oV of gene therapy (Andersen et al. 2000;
Filipp 2007; Sweeney 2004). It is based on the introduction
of genetic vectors into cells (transfection) which carry the
message for the expression of transcripts and proteins.
Today, this is feasible for a number of cell types, i.e. blood,
liver, skeletal muscle, using viral and electroporation based
approaches (Andre and Mir 2004; Gissel 2010). Skeletal
muscle is a particularly attractive host since the large mus-
cle mass can be (ab)used for the local production of biolog-
ical factors (Coelho-Castelo et al. 2006; Louz et al. 2005).
It is generally accepted that methods should be developed
to prevent the abuse of this technology in Sports (Gass-
mann et al. 2005; Haisma and de Hon 2006).
The WADA banns the use of gene doping based on the
deWnition of ‘the non-therapeutic use of genes, genetic ele-
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performance’ (Unal and Ozer Unal 2004; http://www.
wada-ama.org). The doping code speciWes that any biologi-
cal material may be collected for the purposes of Doping
Control (http://www.wada-ama.org). In reality, detection of
gene doping will only be feasible in samples which can be
collected based on accepted codes of practice such as urine
and blood (Hartgens 2008). A number of direct and indirect
methods of detection have been proposed (Baoutina et al.
2010; Haisma and de Hon 2006; Mitchell et al. 2009).
Polymerase chain reaction (PCR) is among the most sensi-
tive technology that would allow detecting gene doping
(Baoutina et al. 2010). This is because it ampliWes deoxyri-
bonucleic acids (DNA) sequences of the introduced genetic
vector or encoded transcript after reverse transcription of
RNA (Kubista et al. 2006). SpeciWcity is directed by the
selective binding of PCR oligonucleotides (primer) to the
matching sequences in the sense and anti-sense strand of
the DNA template which deWne the outer borders of the
amplicon. The ampliWcation reaction bears the important
advantage that the amount of the resulting amplicon is pro-
portional to the initial DNA amount in the sample and lends
itself to a quantitative evaluation through the use of an
ampliWcation standard.
A number of biological processes oVer for the genetic
enhancement of human performance. This includes DNA-
based strategies to promote muscle growth via the activa-
tion of anabolic signal pathways (Striegel and Simon
2007). This has been shown for a number of factors, i.e.
AKT, Erythropoietin (Gassmann et al. 2005; Haisma and
de Hon 2006). Focal adhesion kinase (FAK) is part of the
hypertrophy pathway which integrates hormonal and
mechanical cues in a number of cell types, into the activa-
tion of the protein synthetic pathway (Klossner et al. 2009;
Torsoni et al. 2003). FAK-mediated signalling is regulated
through the phosphorylation of tyrosine residue 397
(pY397) of FAK which reXects the initiation of the phos-
photransfer activity of FAK and allows recruitment of
downstream targets (Hanks et al. 2003). The former post-
translational modiWcation occurs in response to mechanical
loading and endocrine factors such as growth factors (Dur-
ieux et al. 2009; Rozengurt 1995; Shyy and Chien 1997).
Elevated pY397 content with increased loading of skeletal
muscle precedes the phosphorylation of p70S6Kinase
(Klossner et al. 2009) which upregulates ribosomal activity
in a number of cell systems (Volarevic and Thomas 2001).
The implication of FAK-mediated activation of hypertro-
phy signalling is visualized in the increase of mean cross-
sectional area of muscle Wbres 7 days after transfection of
anti-gravitational muscle by gene electro transfer with an
expression construct for FAK (Durieux et al. 2009).
While the detection of genetic modiWcation has been
shown for virus-mediated transfection of skeletal muscle
with expression construct for the secreted hematopoietic
factor erythropoietin (Beiter et al. 2011; Ni et al. 2011) it is
unlikely that this transfection technology would be a
method of choice. This is explained by various drawbacks
including the induction of immune responses that reduce
the success of repeated applications, the costs of production
of GMO quality vectors and possibly fatal consequences
due to the virulence of the approach (Raper et al. 2003). In
consequence, the possibilities for detection of gene doping
by other means of transfection such as gene electrotransfer
and net eVects of gene transfection on muscle structure and
function are not explored.
We hypothesized that the introduction of a naked DNA
vector in skeletal muscle is detectable in the serum of trans-
fected animals as injected introduced plasmid may dissemi-
nates into the body (Coelho-Castelo et al. 2006). This was
tested using established gene therapy for the ampliWcation
of load-dependent hypertrophy signalling via overexpres-
sion of an exogenous FAK homologue from gallus gallus
in rat soleus muscle from a constitutively active expression
plasmid (Durieux et al. 2009). Exogenous and endogenous
FAK sequence was quantiWed with PCR on isolated DNA
using species-speciWc primer pairs. Results were validated
against spiking controls and plasmid standard and measures
after early time points of transfection.
Methods
Study design
Soleus and gastrocnemius muscle of 3-month-old male
Wistar rats was transfected with expression plasmid for
chicken FAK by gene electrotransfer. Blood and muscle
samples were collected and DNA was extracted for ampliW-
cation with polymerase chain reaction using speciWc prim-
ers. In addition, muscle samples were processes for
detection of FAK and muscle Wbre size in cryosections and
p70S6K phosphorylation in immunoblots. Samples from
non-transfected animals served as controls. The timeline of
muscle sampling is shown in Fig. 1a.
Muscle transfection
Soleus muscles of anaesthetized rats (3% isoXurane) were
transfected essentially as described (see Fig. 1b, c; Durieux
et al. 2009). In brief, soleus muscle was surgically exposed
and cytomegalovirus-driven expression construct for the
chicken FAK homologue, pCMV-FAK (1 mg/ml) or an
equivalent amount of empty pCMV-plasmid was injected
into the belly portion of the muscle. Plasmid uptake in mus-
cle Wbres was stimulated by three trains of 80 pulses of
100 s duration, each at 100 mA, at two sites lateral to the123
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erator (EIP Electronique et Informatique du Pilat, Jonzieux,
France). The skin and fascia were closed with sutures and
the animals transferred to single cages. After a day of
reduced cage activity, the behaviour and food intake of
transfected rats could not be distinguished to non-transfec-
ted animals. Measures of body weight demonstrated that
the animals continued to take on weight in the order of
0.3% per day in the week after gene transfer.
In addition, gene electrotransfer was carried out on gas-
trocnemius medialis muscle. 150 g plasmid in 150 l was
injected in the mid portion of the muscle. Subsequently
three trains of 100 pulses of 100 s duration, each at
50 mA, were delivered at two locations lateral to the injec-
tion site.
“Principles of laboratory animal care” (NIH publication
No. 86-23, revised 1985) were followed. The experiments
were performed at the Insel-Hospital of Berne, in Switzer-
land, under approval by the Animal Protection Commission
of the Canton Bern, Switzerland and at the Medical School
of the University of Birmingham with permission of the
Home oYce. The animals were housed in pairs in cages in a
care facility with a 12:12-h light/dark cycle at a constant
temperature of 22°C and maintained on a diet of standard
chow with water ad libitum.
Collection of muscle samples
Soleus and gastrocnemius muscles were extracted from
anesthetized rats 1 h and 7 days after transfection. For
removal of the soleus muscle, a circumferential incision
was made to the skin below the calcaneus. Subsequently,
the distal end of the soleus and its attached tendon were
exposed with the help of forceps. Bleeding started at this
point. The Achilles tendon part of the soleus was grabbed
with a bent clamp and cut with a scalpel. The soleus muscle
was successively lifted from its bed towards the heel of the
knee with the help of the attached clamp. When the ‘semi-
tendinous’ part became apparent at the proximal end of the
soleus muscle, it was cut with a pair of scissors and the
muscle was extracted. Gastrocnemius muscles were har-
vested in separate experiments where the triceps surae
(composed of gastrocnemius medialis and lateralis, soleus
and plantaris) was removed as a whole. This isolation was
achieved by isolating the Achilles tendon as described
above for soleus muscle but then the diVerent heads of the
muscle-tendons were bundled with a surgical thread before
securing them with a clamp. Subsequently, the entire tri-
ceps surae was lifted from its bed with the help of a scalpel,
trimming oV residuals of attached soft tissue. When the
knee heel was apparent, the muscle heads were capped and
Fig. 1 Methodology to trans-
fect skeletal muscle. 
a Experimental protocol; 
b, c Images showing the plasmid 
injection (a) and electropulsing 
(b) of rat soleus muscle
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nitrogen cooled isopentane and stored at ¡80°C until use.
Sampling of blood serum
Blood (0.2 ml) was drawn with a syringe from the ‘tissue
bed’ where the removed, transfected soleus muscle used to
reside before the surgery. Another 0.4 ml of blood was
drawn from the left ventricle, of euthanized animals and
rapidly transposed in heparinized tubes, frozen in liquid
nitrogen, and stored at ¡20°C until analysis.
DNA extraction
Deoxyribonucleic acids were extracted with the DNeasy
Blood and Tissue Kit (QIAGEN Ltd. QIAGEN House
Fleming Way Crawley West Sussex, RH10 9NQ, UK).
Blood samples were extracted using the spin-column
non-nucleated erythrocytes protocol described in the kit
handbook and available at DNeasy website (DNeasy 2006,
http://www.qiagen.com). Final sample volume was 100 l.
On average, 0.02 g total DNA was isolated per 0.2 ml of
serum. Soleus muscle samples were sectioned in a cryostat
(Leica) at a thickness of 12 m to aid the lysation process.
An estimated volume of 25 mm3 of sample was used during
the protocol for the extraction of DNA from animal tissues.
Extracted DNA was stored in ¡20°C freezer.
Polymerase chain reaction
Reverse and forward oligonucleotide primers were
designed using Primer Express software (PE Biosystems,
Rotkreuz, Switzerland) and Basic Local Alignment Search
Tool (BLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi) to
detect unique sequences in the homologous sequence of the
respective rat (Genbank AF020777) of chicken FAK homo-
logues (Genbank M86656). The sequence of the two primer
pairs is shown in Fig. 2a. Due to the imposed limitations, a
chance for primer dimers existed.
PCRs were run on the isolated DNA with FAK-speciWc
primers with SYBR Green Master Mix chemistry (Bio-Rad
Laboratories Ltd, Hemel Hempstead, UK) on a Xuores-
cence PCR machine (DNA machine, Bio-RioRad) operated
by Opticon 3 monitor software. Reactions were run with
1 l of DNA sample in a Wnal volume of 21 l within 96-
well plates based on the Opticon 3 monitor instructions.
The PCR protocol comprised an activation step (95°C for
5 min) and 50 cycles of denaturing (95°C for 15 s), anneal-
ing (55°C for 1 min) followed by a read of the Xuorescence
on the well. This was terminated by melting curve analysis
with a protocol rising the temperature in steps of 0.5°C
(held 1 s) from 55 to 95°C. The cycle of threshold detection
Ct was estimated using the Opticon 3 software.
The eYciency of the PCR ampliWcation was quantiWed
in titration experiments with pCMV-FAK plasmid and
chicken FAK-speciWc primers. The eYciency was assessed
from the slope of linear relationship between the input
DNA (i.e. plasmid) and the Ct of PCR ampliWcation. Plas-
mid DNA amounts were determined against a standard
curve as determined with PCR on a dilution series of
pCMV-FAK plasmid. For the spiking experiments, pCMV-
FAK plasmid was mixed with DNA sample from blood
serum of a non-transfected, control rat at a concentration of
50 femtogram/microliter.
Immunoblotting
Soleus muscles were cryosectioned at 12 m and total
homogenate was prepared in modiWed RIPA buVer (1%
NP-40, 0.25% deoxycholate, 50 mM Tris HCl, pH 7.4,
1 mM EDTA, 150 mM NaCl, 1 mM NaF, 1 mM PMSF,
1 mM sodium orthovanadate, 1 g/ml leupeptin, 2 g/ml
pepstatin, 1 g/ml aprotinin; all reagents were received
from Sigma-Aldrich (Dorset, England). Protein concentra-
tion was quantiWed with Bicinchoninic acid assay reagents
against BSA standard (Pierce, Thermo Fisher ScientiWc,
Cramlington, UK). Twenty micrograms of protein were
separated by SDS-PAGE, western blotted onto protran
nitrocellulose (Schleicher & Schuell BioScience GmbH,
Whatman Group Hahnestrasse 3, D-37586 Dassel, Ger-
many) and subjected to immunodetection with p70S6K
antibody (C-18, Santa Cruz, CA, USA) as described
(Klossner et al. 2009). Signal detection was carried out with
enhanced chemoluminescence using a Geldoc system that
was operated using Quantity One 1-D analysis software
4.6.1 (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK).
Signal intensity of the p70S6K bands was determined using
the rectangle density mode and background from an empty
sample lane was subtracted.
ImmunoXuorescence
Detection of FAK in soleus and gastrocnemius muscle
was carried out essentially as described in Klossner et al.
(2009). In brief, 12-m cryosection were incubated with
the FAK N-terminal antibody A-17 from rabbit (1:100
dilution, Santa Cruz) and Alexa Fluor 488-coupled sec-
ondary anti-rabbit antibody (DAKO, Denmark). Fluores-
cence and digital phase contrasts were recorded using a
TCS SP5 confocal microscope (Leica Microsystem CMS,
Mylton Keynes, UK). Mean cross-sectional area of Wbres
overexpressing FAK or showing background levels in
stained cryosections (=not-overexpressing Wbres) was
quantiWed using the macro application of Leica Applica-
tion Suite (LAS). Towards this end, random images were
taken at a 20-fold magniWcation from microscopic Welds123
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muscle showing FAK overexpression. FAK-transfected
Wbres were identiWed in each image. Then the circumfer-
ence—as identiWed with the digital phase contrasts—was
circled with the quantiWcation tool of LAS to estimate
cross-sectional area. For each image, the cross section of
clearly demarcated FAK-overexpressing and not-over-
expressing muscle Wbres was measured. Raw data were
exported for statistical analysis.
Statistics
T tests were carried out to compare the calculated plasmid
amounts between the samples. The signiWcance was set to
5%. Results are graphical represented.
Results
Muscle transfection
Figure 1 visualises the methodology employed to transfect
soleus muscle of rats with cytomegalovirus-driven expres-
sion construct for the chicken FAK homologue, pCMV-
FAK. One hundred and Wfty micrograms of plasmid were
injected into the exposed muscle which uptake in muscle
Wbres was subsequently stimulated by electric pulses (elec-
tro gene transfer). The biological eVect of transfection was
analyzed 7 days later. Microscopic examination identiWed
muscle Wbres which demonstrated sizeably increased
expression of FAK protein in the sarcoplasm (Fig. 3a, c).
M. soleus being injected with empty, pCMV-plasmid did
Fig. 2 a Sequence alignment of the primers used to amplify the nucle-
otide sequence of the exogenous (chicken) FAK and endogenous (rat)
FAK. b, c melting and ampliWcation curve of 100 femtogram/microli-
ter pCMV-FAK plasmid as ampliWed with chicken speciWc FAK-prim-
er. d Titration curve indicating the linear ampliWcation of the pCMV-
FAK amplicon with chicken speciWc FAK primer between 0.01 and
100 femtogram plasmid per microliter
A
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shown). QuantiWcation revealed a transfection eYciency of
12% in the targeted soleus muscle. The targeted muscle
Wbres demonstrated on average a 5.5-fold increase in FAK
signal intensity (i.e. expression). Their mean cross-sec-
tional area was 52% larger compared to Wbres with baseline
FAK levels. Concomitantly, with pCMV-FAK transfection,
the protein levels of p70S6K were 2.1-fold increased
(Fig. 3e, f).
We transfected the medial portion of gastrocnemius
muscle with pCMV-FAK (Fig. 3b). Transfection eYciency
was 4.5% in the targeted muscle portion. The Xuorescent
signal for FAK was 73-fold elevated in transfected Wbres.
Mean cross-sectional area was 16% larger in muscle Wbres
which overexpressed FAK (Fig. 3d).
Establishing the detection of expression construct
An oligonucleotide pair was designed to detect the expres-
sion plasmid pCMV-FAK with PCR-based ampliWcation of
a unique nucleotide segment in the exogenous (chicken
FAK) DNA sequence of the plasmid (Fig. 2a). The criteria
for the nucleotide pair were that the primers complied with
the default settings for SYBR and Taqman biochemistry
and would allow separating the exogenic from the endoge-
nous (rat) FAK homologue.
Fig. 3 Biological eVect of mus-
cle transfection with expression 
construct for the chicken FAK 
homologue. Microscopic exami-
nation of Xuorescently stained 
FAK (light grey/red) in soleus 
(a) and gastrocnemius medialis 
muscle (b) 7 days after gene 
electrotransfer with pCMV-
FAK plasmid. Mean cross-sec-
tional area of FAK overexpress-
ing (‘+’) and not-overexpressing 
muscle Wbres (‘¡’) of m. soleus 
(c, n = 33 vs. 94 Wbres) and m. 
gastrocnemius (d, n = 21 vs. 44 
Wbres). The data were collected 
from cross sections of transfec-
ted muscle from three animals, 
each. e Example of p70S6K in 
20 g total protein from empty 
pCMV (‘¡’) and pCMV-FAK 
(‘+’) transfected soleus muscle 
sample as detected by immuno-
blotting. f Fold-change in 
p70S6K protein with pCMV-
FAK transfection of soleus mus-
cle. Asterisk denotes p < 0.05 
versus the non-transfected mus-
cle (Wbre)
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Wcation of a speciWc amplicon with a length of 69 bp and a
melting temperature of 83.5°C in PCR with pCMV-FAK
plasmid DNA (Fig. 2b). The calculated threshold of detec-
tion was estimated to situate at 0.01 femtogram/microliter.
Quantifying plasmid levels in blood of transfected rats
Spiking experiments with DNA from blood serum
(=‘serum DNA’) from non-transfected rats showed that the
detection of the pCMV-FAK plasmid is feasible (Fig. 4a).
In serum DNA samples from non-transfected rats detection,
endogenous background was ampliWed in late cycle of the
PCR (Ct = 38; data not shown).
We analyzed DNA from blood serum of somatically
transfected rats to assess whether the inserted plasmid is
detectable with PCR using the chicken FAK-speciWc prim-
ers. The plasmid could be detected in serum DNA that had
been collected from the muscle bed 1 h after injection of
75 g pCMV-FAK into soleus muscle and surgery (the
‘muscle site’; Fig. 5a). The amplicon was not detected
above the background in DNA from blood collected from
heart after the same time point of transfection.
In serum DNA that had been collected 7 days after elec-
tro gene transfer of soleus muscle, the chicken FAK ampli-
con could not be detected above background levels seen in
non-transfected rats (Fig. 5b).
A second oligonucleotide primer pair was designed to
detect a segment in the endogenous (rat) FAK transcript
(Fig. 2a). Control experiments with this probe showed that
endogenous FAK was detectable in serum DNA indepen-
dent of muscle transfection (Fig. 4e, f).
Fig. 4 PCR detection of exoge-
nous FAK in DNA samples from 
rats which soleus muscle was 
transfected with pCMV-FAK. a, 
b Screen plots of ampliWcation 
and melting curve for a PCR 
using chicken FAK primer pairs 
on serum DNA from a non-
transfected rat muscle being 
spiked with 50 femtogram/
microliter pCMV-FAK. c, 
d AmpliWcation and melting 
curves of a PCR of a cDNA sam-
ple from pCMV-FAK-transfec-
ted rat soleus muscle. e, f PCR 
using rat FAK-speciWc primers 
on serum DNA of a rat with 
pCMV-FAK transfected soleus 
muscle (dark/red line) and 
serum DNA of a non-transfected 
control rat. Note the similar 
threshold of detection for the 
endogenous FAK gene transcript123
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PCR experiments with transfected muscle sample showed
that the detection of pCMV-FAK plasmid is feasible in
DNA being isolated from soleus muscle 1 h after plasmid
injection. Seven days after transfection, detection of the
chicken FAK amplicon was retained in cDNA of the
soleus muscle being transfected with pCMV-FAK
(Figs. 4c, 5b).
Discussion
Doping represents a major threat for health and interferes
with the ideal of fairness in athletic competition. While it is
not currently understood to which extent gene doping is
currently in use and possibly Wctive (Andersen et al. 2000;
Glogger 2008), gene doping is on the list of banned inter-
ventions without Wrm methods for its detectability being
established (Gassmann et al. 2005). Towards this end, we
addressed in a test system for hypertrophy signalling via
focal adhesion kinase, whether more recently introduced
blood tests would be an option to detect somatic gene ther-
apy with sensitive PCR technology. Our experiments pro-
vide novel evidence for anabolic reactions in FAK
transfected muscle Wbres and emphasize that detection of
exogenous gene sequences is possible on pure DNA that
has been isolated with commercial kits from the hypertro-
phied muscle after transfection. By contrast, detection is
not necessarily feasible in DNA being prepared from blood
serum. These observations have a number of implications
for the biological eVects and diagnostics of gene doping in
Sports.
Biochemical and cellular measures of the targeted soleus
muscle imply that the enhancement of FAK expression by
genetic means elevates cross-sectional area of muscle Wbres
and increases in the expression of the phosphotransfer
enzyme p70S6kinase (Fig. 3e, f). This signalling factor cor-
relates strongly with the degree of muscle hypertrophy
(Zanchi and Lancha 2008). We have previously shown that
reloading of atrophied soleus muscle increases phosphory-
lation of p70S6K at regulatory amino acids (Klossner et al.
2009). This Wnding indicates that the anabolic eVect of
FAK overexpression in the postural muscle under study
reXects the ampliWcation of load-induced hypertrophy sig-
nalling.
We also targeted gastrocnemius medialis muscle and
found that the cross-sectional area of FAK-transfected
muscle Wbres was signiWcantly increased compared to
non-transfected muscle Wbres as well (+16%, p = 0.04).
This degree of hypertrophy is smaller than that seen for
transfected soleus (52%) muscle despite heavier eleva-
tions in FAK expression levels (73- vs. 7-fold). This dis-
crepancy possibly reXects diVerent Wbre type composition
in soleus and gastrocnemius medialis muscle (DeRuiter
et al. 1996; Fluck et al. 2002). Using an antibody that is
now understood to detect the activated FAK molecule
(Durieux et al. 2009), we have shown that FAK activation
relates to the recruitment of muscle Wbres types (Fluck
et al. 2002). The predominately slow type motor units in
soleus muscle are frequently implicated in load-bearing
muscle action with daily movement patterns (i.e. 22–35%
of the total time (Hennig and Lomo 1985). By contrast,
the fast type motor units of gastrocnemius muscle are
mainly involved in propulsion and thus far less frequently
activated in laboratory animals (i.e. <5% of total activity).
The comparison of the two muscle types supports the
notion that the outcome of recruitment-induced FAK sig-
nalling is diVerent in slow and fast type muscle Wbres of
anti-gravitational muscle.
Having established the principal feasibility of detecting
introduced DNA in serum via ampliWcation of exogenous
DNA segment, we were unable to speciWcally amplify the
same sequence in serum collected 7 days after the inter-
vention. Similarly, the pCMV-FAK plasmid was not
detectable in serum DNA from samples collected from the
Fig. 5 Time course for PCR detection of exogenous FAK in serum of
transfected rats. Calculated amount of pCMV-FAK plasmid in blood
serum (a) and muscle samples (b) from soleus muscles of transfected
and non-transfected rats. Serum samples were collected close to the
site of pCMV-FAK plasmid injection (‘muscle site’) or the left ventri-
cle (‘heart’) 1 day or 7 days after plasmid injection. Asterisk indicates
p < 0.05 based on a T test
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muscle, but when the exogenous FAK sequence was
detectable is serum collected close to the site of DNA
injection (Fig. 5a). Meanwhile, the sequence of the
endogenous FAK could be ampliWed at a similar level in
serum DNA of non-transfected control rat as in serum
from rats with pCMV-FAK transfected soleus muscle
(Fig. 4e, f). The positive control experiment indicates that
the DNA yield and quality were not limiting factors in our
experiments. Our data compare to observations comment-
ing on the narrow time window under which injected
DNA can be detected in the circulation (Baumgartner
et al. 2009). There was minor surgical injury to the trans-
fected soleus muscle. We, therefore, estimate that the
pCMV-FAK plasmid that could be detected in serum sam-
pled close to the site of DNA injection originates from the
remainder of DNA material which leaked from the elec-
tropulsed soleus into the tissue bed or blood normally
entering or exiting the soleus muscle. Our observations
indicate that dilution eVects in the serum compartment or
eventually rapid DNA elimination reduce the chances of
detecting gene doping in blood samples collected distant
to the site of local genetic treatment.
This relates to a very recent report demonstrating that
intramuscularly injected conventional plasmid is rapidly
eliminated (Ni et al. 2011). Equally we noted that the signal
for exogenous FAK was importantly reduced in transfected
soleus muscle 7 days after transfection. The Wndings imply
that the detection of somatic gene therapy with the
employed PCR technology is conWned to a narrow spatial–
temporal window after the intervention.
Dilution experiments with pCMV-FAK plasmid
showed that the exogenous FAK sequence is not detect-
able with our PCR setup above background below 0.01
femtogram/microliter reaction mix. PCR experiments
with water only imply that the background is explained by
the ampliWcation of primer dimers (data not shown). Due
to the imposed restrictions for amplicon length, the back-
ground PCR product was indistinguishable based on melt-
ing temperature to the speciWc product from pCMV-FAK
plasmid ampliWcation. We calculate that the threshold
level for detection of exogenous FAK by PCR corre-
sponds to a ratio of plasmid to total DNA of 1:10,000
(w/w). Quantitative considerations further indicate that
only a minor portion of the original 150 g of the plasmid
being injected in soleus muscle (i.e. 1/125,000) is detect-
able in blood serum. Based on the volumes used to inject
plasmid before electropulsing, we estimate that the detec-
tion of injected plasmid would not be technically feasible
below a concentration an injected amount of 50 g in our
rat system. Thus when larger targeted tissues are targeted
with similar DNA amounts, it is unlikely detectable with
the employed PCR technology.
Conclusions
Our assays in a model system for somatic transgenesis indi-
cate that the option to detect gene doping with conventional
PCR is gone 7 days after the DNA intervention. Given this
short window of detection, this indicates that a change in
current sampling practice is indicated to provide anti-dop-
ing panels with the diagnostic power to detect gene doping.
This should involve the collection of muscle biopsies
within the Wrst week after DNA injection at the suspected
site of the genetic intervention.
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